MedPath

Effect of Barley Supplemented Wheat Bread on Markers of Cardiovascular and Renal Health

Not Applicable
Completed
Conditions
Cardiovascular Diseases
Kidney Diseases
Interventions
Other: Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health
Registration Number
NCT05312788
Lead Sponsor
Khyber Medical University Peshawar
Brief Summary

The disruption of colonic microbiota has been linked to a number of diseases, mainly cardiovascular and kidney diseases. One possible means to improve the microbiota is to increase dietary fiber intake as the intake of dietary fiber shifts the fermentation from proteolytic saccharolytic fermentation.

Beta-glucans are soluble dietary fibers mainly found in oats and barley. Results from previous studies suggest that the consumption of barley reduces the risk of cardiovascular and kidney diseases. Therefore, this study will explore the effect of barley beta-glucans on markers of Cardiovascular and Renal health.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Healthy individuals of age 18 years or older
  • BMI ranged between 18.5 and 24.9
Exclusion Criteria
  • Celiac disease, Cancer, Diabetes , cardiovascular diseases
  • Gastro intestinal tract disease
  • Pregnant women
  • Use of pre-, pro- or antibiotics 15 days before the enrollment into the study
  • Food allergy to food used in the trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Whole wheat breadEffect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal HealthWhole wheat bread will be used as control bread.
Barley supplemented wheat breadEffect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal HealthBarley supplemented wheat bread (50% substitution) will be used as experimental bread.
Primary Outcome Measures
NameTimeMethod
Change in Serum Nitric oxide from baseline to 4 weeksBaseline and after 4 weeks
change in Serum E-selectin from baseline to 4 weeksBaseline and after 4 weeks
Change in Serum P-cresyl sulfate from baseline to 4 weeksBaseline and after 4 weeks
Change in Serum Thiobarbituric acid reactive substances (TBARs) from baseline to 4 weeksBaseline and after 4 weeks
Change in Serum Total antioxidant capacity (TAC) from baseline to 4 weeksBaseline and after 4 weeks
Change in Serum Indoxyl sulfate from baseline to 4 weeksBaseline and after 4 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Khyber Medical University, Peshawar

🇵🇰

Peshawar, KPK, Pakistan

© Copyright 2025. All Rights Reserved by MedPath